Anzeigenschluss: 25.04.2025
Erscheinungstermin: 19.05.2025
Schwerpunkt: Multiples Myelom
M. Höger
Editorial
S. Lorenzen
Therapie und Übersicht
Journal Club
Prostatakarzinom
Marshall et al.
Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled Trial
NSCLC
Sorin et al.
Neoadjuvant chemoimmunotherapy for NSCLC (Non-Small Cell Lung Cancer). A systematic review and meta-analysis
Neuroonkologie
Kacimi SEO et al.
Survival outcomes associated with first-line procarbazine, CCNU, and vincristine or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma
Allgemeine Onkologie
Benoit et al.
Coaching doctors to improve ethical decision-making in adult hospitalized patients potentially receiving excessive treatment. The CODE stepped-wedge cluster randomized controlled trial
Neues aus der Forschung
Leukämie
Karpova et al.
Clonal Hematopoiesis Landscape in Frequent Blood Donors
Supportivmedizin
Michel et al.
Efficacy of Hand Cooling and Compression in Preventing Taxane-Induced Neuropathy: The POLAR Randomized Clinical Trial
Brustkrebs
Lambertini et al.
Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status
HPV assoziierte Tumoren
Floudas CS et al.
Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical Trial
CME Fortbildung
Gynäkoonkologie
M. Eichbaum
Immuntherapie Endometrium-Karzinom
Onkologie aktuell
Kongressbericht 1
50th Annual Meeting of the EBMT
Kongressbericht 2
European Lung Cancer Congress (ELCC 2025)
*Die Redaktion behält sich aktuelle Änderungen vor.